Advanced search
Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 74, 2019 - Issue 3
Submit an article Journal homepage
118
Views
4
CrossRef citations to date
0
Altmetric
Case report

Fixed drug eruption due To 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect

Fatma ErdenDepartment of Dermatology and Venereology, Ankara Occupational Diseases Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Erol Rauf AgisClinic of Pharmacology, Ankara Occupational Diseases Hospital, Ankara, Turkey
,
Meside GunduzozClinic of Family Medicine, Ankara Occupational Diseases Hospital, Ankara, Turkey
&
Omer Hinc YilmazDepartment of Public Health, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Pages 200-202 | Published online: 18 Jun 2018

References

  • Djien V, Bocquet H, Dupuy A, et al. Symptomatology and markers of the severity of erythematous drug eruptions. Ann Dermatol Venereol. 1999 Mar;126(3):247–250.
  • Heng YK, Yew YW, Lim DSY, et al. An update of fixed drug eruptions in Singapore. J Eur Acad Dermatol Venereol. 2015;29(8):1539–1544.10.1111/jdv.2015.29.issue-8
  • Breathnach SM. Drug reactions. In: Burns T, Breathnach S coxn, Griffiths C, editor. Rook’s textbook of dermatology. Oxford: Blackwell Publishing; 2010. p. 28–30.
  • Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. 1998;37:833–838.10.1046/j.1365-4362.1998.00451.x
  • Aposhian HV. DMSA and DMPS-water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol. 1983;23:193–215.10.1146/annurev.pa.23.040183.001205
  • Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139:49–58.10.1046/j.1365-2133.1998.02313.x
  • Ozkaya-Bayazit E. Topical provocation in fixed drug eruption due to metamizol and naproxen. Clin Exp Dermatol. 2004;29:419–422.10.1111/ced.2004.29.issue-4
  • Research Triangle Institute; Agency for toxic substances and disease registry. Toxicological profile for mercury. Atlanta. Department of Health and Human Services. 1999.
  • Caravati EM, Erdman AR, Christianson G, et al. Elemental mercury exposure: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2008;46:1–21.10.1080/15563650701664731
  • Garcia D, Cohen PR. Dapsone-associated fixed drug eruption. Expert Rev Clin Pharmacol. 2017 Jul;10(7):717–725.10.1080/17512433.2017.1322508
  • Holtzer CD, Flaherty JF Jr, Coleman RL. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Pharmacotherapy. 1998 Jul–Aug;18(4):831–835.
  • Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS. 1993 Jan;7(1):65–71.10.1097/00002030-199301000-00010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.